Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-17,500
Closed -$312K 3431
2021
Q4
$312K Buy
17,500
+600
+4% +$11.5K ﹤0.01% 3619
2021
Q3
$321K Sell
16,900
-4,400
-21% -$73K ﹤0.01% 3617
2021
Q2
$458K Buy
+21,300
New +$459K ﹤0.01% 3183
2021
Q1
Sell
-38,100
Closed -$687K 4017
2020
Q4
$687K Buy
+38,100
New +$525K ﹤0.01% 2274
2018
Q2
Sell
-10,000
Closed -$192K 3470
2018
Q1
$192K Buy
+10,000
New +$208K ﹤0.01% 2987
2017
Q4
Sell
-35,800
Closed -$811K 3251
2017
Q3
$811K Buy
+35,800
New +$738K ﹤0.01% 1851

Other funds holding IMAX

John Overdeck's IMAX Position: Q2 2026 in Review

John Overdeck reduced its IMAX (IMAX) stake by 59% in Q2 2026, selling an estimated $15.7M and leaving 281,421 shares worth $11.2M. The position accounts for 0.01% of the portfolio, ranked #1449.

John Overdeck first reported a position in IMAX in Q4 2014 and has held it in 43 quarters since. The position peaked at $26.3M in Q1 2026. 255 funds tracked by Wall St. Rank hold IMAX as of Q2 2026.

  • John Overdeck held 281,421 shares of IMAX worth $11.2M as of Q2 2026.
  • John Overdeck sold 410,053 IMAX shares in Q2 2026, an estimated $15.7M.
  • IMAX made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1449 holding.
  • John Overdeck first reported a position in IMAX in Q4 2014 and has held it in 43 quarters since.
  • John Overdeck's IMAX position peaked at $26.3M in Q1 2026.
  • 255 funds tracked by Wall St. Rank held IMAX as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.